Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Teriparatide Pen Injector [Forteo]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background: Due to high cost and burden of osteoporosis, it is reasonable to focus on the reduction of fractures as the main goal… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2016
2016
SummaryThere is a strong impetus to prevent and treat osteoporosis to prevent fractures. $990 million dollars was spent on anti… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2009
Review
2009
SummarySince approval by the U.S. Food and Drug Administration (FDA) in December 2002, teriparatide (recombinant 1-34 PTH; Forteo… Expand
  • figure 1
Is this relevant?